Key Highlights
- Kristin Judge appointed as Chief Commercial Officer of Catalyst Clinical Research.
- Effective Date: July 29, 2024.
- Role: Lead commercial functions and drive sales performance.
- Brings over 17 years of experience in biotech and pharmaceutical CRO services.
Source: PR Newswire
Notable Quotes
- “Kristin has the depth of commercial experience to support Catalyst’s continued growth. This is an amazing opportunity to guide Catalyst Clinical Research through its next period of growth.” — Nik Morton, President and CEO at Catalyst Clinical Research
- “Catalyst aligns directly with my strong belief that you can have a company with a positive team culture, people who care about each other.” — Kristin Judge, Chief Commercial Officer at Catalyst Clinical Research
SoHC's Take
The appointment of Kristin Judge as the first Chief Commercial Officer at Catalyst Clinical Research signifies a strategic move to bolster the company’s commercial capabilities. With her extensive experience across biotech, pharmaceutical services, and life sciences technologies, Judge is well-positioned to lead Catalyst’s commercial team toward enhanced sales performance and sustained growth. Her previous roles at prominent organizations like Emmes, Veeva Systems, and Labcorp Drug Development underscore her capability to drive Catalyst’s growth in a highly competitive CRO market. This move aligns with Catalyst’s vision of a differentiated and customer-centric service model, likely setting the stage for continued success in the global biopharmaceutical industry.
